Table 1 Patients characteristics
Control | ICD | p | |
|---|---|---|---|
(n = 143) | (n = 70) | ||
Age in years, mean (±SD) | 67.9 ± 9.8 | 64.8 ± 9.9 | 0.034 |
Gender, women, n (%) | 26 (18.2 %) | 6 (8.6 %) | 0.065 |
Coronary artery disease (CAD) | |||
1-vessel CAD, n (%) | 16 (11.2 %) | 16 (22.9 %) | 0.025 |
2-vessel CAD, n (%) | 41 (28.7) | 23 (32.9) | 0.531 |
3-vessel CAD, n (%) | 86 (60.1) | 31 (44.3) | 0.029 |
Left ventricular ejection fraction (LVEF), % | 29.1 ± 4.6 | 26.7 ± 6.3 | 0.006 |
LVEF, women, % | 29.4 ± 4.5 | 28.7 ± 7.7 | |
LVEF, men, % | 29.0 ± 4.7 | 26.5 ± 6.1 | |
LVEF, 1-vessel CAD, % | 29.4 ± 4.2 | 26.3 ± 7.0 | |
LVEF, 2-vessel CAD, % | 28.7 ± 4.7 | 25.2 ± 7.1 | |
LVEF, 3-vessel CAD, % | 29.3 ± 4.7 | 28.1 ± 5.0 | |
Diabetes, n (%) | 56 (39.2) | 24 (34.3) | 0.490 |
Pharmacotherapy, n (%) | |||
Betablockers | 132 (93.0) | 68 (97.1) | 0.215 |
ACE inhibitors | 110 (77.5) | 59 (84.3) | 0.245 |
ARBs | 19 (13.4) | 6 (8.6) | 0.307 |
Statins | 93 (65.5) | 57 (81.4) | 0.017 |
Diuretics | 125 (88.0) | 58 (82.9) | 0.303 |
Antiarrhythmics (Amiodarone) | 6 (4.2) | 3 (4.3) | 0.984 |
Anticoagulation | 51 (35.9) | 27 (38.6) | 0.706 |